ClinicalTrials.gg
RecruitingNCT07347873Updated Jan 16, 2026

Diagnostic Accuracy of the Clinical Tests and the Ultrasonography in Lateral Elbow Tendinopathy

An observational study in Lateral Elbow Tendinopathy (Tennis Elbow), sponsored by Marmara University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-16.

Sponsored by Marmara University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 82 studies in Tennis Elbow with a site in Turkey — 20 open to participants now, 21 under way, none of them phase 3. Tennis Elbow · Turkey.

Planned enrollment
7th of 12
100 · median 104
Started
2025
with 16 others
Observational
12 of 82
6 open now
Primary completion
2026-01
later than 4 of 20 live
Registered
60th of 82
by date
Lead sponsor
3 of 82
Marmara University

Among the 82 studies in Tennis Elbow with a site in Turkey, this one is the 7th largest by planned enrollment of the 12 observational ones that give a count, is one of 17 that started in 2025, is one of 12 observational ones, reaches primary completion later than 4 of the 20 other live ones, and was the 60th registered.

Tennis Elbow

296 studies on the registry are indexed under Tennis Elbow; 63 are open to participants now.

Browse Tennis Elbow studies →

Open to participants now

20 of the 82 studies in Tennis Elbow with a site in Turkey are open now. Recruiting first, the newest first:

14 more — sign in →

All 20 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 42 Tennis Elbow studies recruiting now, 8 (19%) set no upper age limit and 31 (74%) stop at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 82 studies in Tennis Elbow with a site in Turkey, or all of them as a file.
02

Study summary

Lateral elbow tendinopathy (LET) is the most common cause of elbow pain. Even though provocation tests such as Cozen's test, Mill's test or Maudsley test; musculoskeletal ultrasound or magnetic resonance imaging can be used for diagnosis, gold standard method is yet to be determined. Purpose of this study is to determine the sensitivity and specificity of clinical tests and ultrasonography in diagnosis of LET.

03

Conditions studied

  • Lateral Elbow Tendinopathy (Tennis Elbow)

Browse trials for

Keywords

  • Elbow pain
  • Lateral epicondylitis
  • Cozen
  • Elastography
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients presented to the outpatient clinic of Physical Medicine and Rehabilitation of Marmara University with elbow pain and diagnosed with lateral epicondylitis will be informed about the study. Willing patients will be enrolled after written consent is taken.

Control group will be chosen with volunteers, which have similar demographic characteristics.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18-60 with unilateral elbow pain
  • Tenderness with palpation at the lateral epicondyle
  • Pain triggered with pressure compared to the opposite lateral epicondyle with algometer.

Exclusion criteria

Exclusion Criteria:

  • History of rheumatologic diseases
  • History of e injections on lateral epicondyle
  • History of elbow surgery or infection
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Lateral elbow tendinopathy

    Patients with lateral epicondylitis will be included in this group.

  • Control

    Healthy volunteers with similar demographic characteristics will be enrolled to this group.

06

What researchers measure

Primary outcomes

  1. Elastography

    Both shear wave and strain elastography will be applied. Stiffness and shear wave velocity will be calculated on shear wave elastography and strain ratio will be calculated on strain elastography.

    Time frame: At enrollment

Secondary outcomes

  1. Musculoskeletal ultrasound

    Sonographic evaluation will begin with gray scale examination. Swelling, cortical irregularity, hypoechogenicity, calcification, tear common extensor tendon thickness will be assessed. Power doppler will be evaluated between the superficial fibers of the common extensor tendon, the bone surface, the insertion point of the common extensor tendon and the humeroradial joint. Doppler activity will be graded based in a 0.5-cm longitudinal part of the tendon with the maximal Doppler activity (the region of interest-ROI). The 5-point grading will be as follows. Grade 0: No activity, Grade 1: Single vessel, Grade 2: Doppler activity in 0-25% of the ROI, Grade 3: Doppler activity in 25-50% of the ROI, Grade 4: Doppler activity in \>50 of ROI. Lastly elastography will be used.

    Time frame: At enrollment

  2. Cozen's test

    Resisted wrist extension will be performed while patient is sitting and elbow on extension. Cozen's test will be applied to both extremities. Pain felt on the lateral epicondyle during provocation indicates a positive test result.

    Time frame: At enrollment

  3. Maudsley's Test

    Resisted third finger extension will be performed while patient is sitting and elbow on 90 degrees flexion. Maudsley's test will be applied to both extremities. Pain felt on the lateral epicondyle during provocation indicates a positive test result.

    Time frame: At enrollment

  4. Mill's test

    Maximal wrist flexion will be performed while patient is sitting, elbow on extension and forearm pronation. Mill's test will be applied to both extremities. Pain felt on the lateral epicondyle during provocation indicates a positive test result.

    Time frame: At enrollment

  5. Hand Grip Strength

    Both painless and maximum grip strength will be examined using Jamar's hand dynamometer.

    Time frame: At enrollment

  6. Algometer

    Force will be applied to lateral epicondyle using an algometer.

    Time frame: At enrollment

  7. Patient Rated Tennis Elbow Evaluation

    Patient Rated Tennis Elbow Evaluation will be used to assess pain and functional status in patients diagnosed with LET.

    Time frame: At enrollment

07

Study locations

1 of 1 sites recruiting
  • Marmara University
    Istanbul, Maltepe 34844, Turkey (Türkiye)
    Recruiting
    • Arda Can Kasap, M.D. · Contactdrardakasap@gmail.com · 902166254545
    • Arda Can Kasap, M.D. · Sub investigator
    • İlker Yağcı, Prof. M.D. · Principal investigator
    • Naime Evrim Karadağ Saygı, Prof. M.D. · Sub investigator
08

References and documents

Publications

  • Krogh TP, Fredberg U, Ammitzboll C, Ellingsen T. Clinical Value of Ultrasonographic Assessment in Lateral Epicondylitis Versus Asymptomatic Healthy Controls. Am J Sports Med. 2020 Jul;48(8):1873-1883. doi: 10.1177/0363546520921949. Epub 2020 Jun 2. PubMed 32484714 ↗
  • Hong S, Hahn S, Yi J, Park EJ, Bang JY. Comparing the clinical application of strain elastography and shear wave elastography for the evaluation of lateral epicondylitis. J Clin Ultrasound. 2023 Jan;51(1):123-130. doi: 10.1002/jcu.23356. Epub 2022 Sep 28. PubMed 36169174 ↗
  • Karanasios S, Korakakis V, Moutzouri M, Drakonaki E, Koci K, Pantazopoulou V, Tsepis E, Gioftsos G. Diagnostic accuracy of examination tests for lateral elbow tendinopathy (LET) - A systematic review. J Hand Ther. 2022 Oct-Dec;35(4):541-551. doi: 10.1016/j.jht.2021.02.002. Epub 2021 Feb 27. PubMed 33814224 ↗

Individual participant data

Plan to share: No — Due to legal restrictions, all data will be anonymized. Individual participant data won't be shared to third parties.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2025 (actual). Primary completion is estimated for Jan 2026, 3 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 24, 2025
First posted
Jan 16, 2026
StartActual
Oct 17, 2025
Primary completionEst.
Jan 31, 2026
CompletionEst.
Mar 26, 2026
Last update
Jan 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07347873
Lead sponsor
Marmara University
Responsible party
İlker Yağcı (Prof. M.D., Marmara University) — Principal investigator
First posted
Jan 16, 2026
Start date
Oct 17, 2025
Primary completion
Jan 31, 2026 (estimated)
Completion
Mar 26, 2026 (estimated)
Last update
Jan 16, 2026

Study contacts

Arda Can Kasap, M.D.
Contact
drardakasap@gmail.com
+902166254545
İlker Yağcı, Prof. M.D.
principal investigator · Acıbadem Ataşehir Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion